Finding new ways to diagnose malaria.
Official title: NOVEL DIAGNOSTIC BIOMARKERS DISCOVERY AND VALIDATION FOR MALARIA
Funded at L2 Diagnostics, LLC · NIH-11303098 · Data updated 2026-11-12
This study is looking for new ways to test for malaria more accurately and quickly, which could help patients get the right treatment sooner and feel better faster.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | L2 Diagnostics, LLC NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | December 1, 2024 |
| Project end | November 30, 2025 |
| Funding year | 2025 |
| Award (this year) | $300,000 |
| NIH project number | 75N93025C00004-0-9999-1 |
| Project ID | NIH-11303098 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who are suspected of having malaria or are at high risk for malaria infections.
✕Less likely to help
Patients who have already been diagnosed and treated for malaria may not receive additional benefits from this research.
What this research studies
This research focuses on discovering and validating new diagnostic biomarkers for malaria, specifically targeting the Plasmodium falciparum parasite. By identifying unique biological markers associated with malaria infections, the project aims to improve the accuracy and speed of malaria diagnosis. Patients may benefit from more reliable testing methods that can lead to timely treatment and better health outcomes. The research employs advanced techniques in biomarker discovery and validation to ensure the effectiveness of the new diagnostics.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and timely diagnoses of malaria, improving patient care and treatment outcomes.
How similar studies have gone: Other research has shown success in developing novel diagnostic methods for infectious diseases, indicating potential for this approach in malaria diagnostics.
Where this research is happening
-
L2 Diagnostics, LLC
New Haven, United States Active
Researchers
- Principal investigator: Ledizet, Michel — L2 Diagnostics, LLC
- Study coordinator: Ledizet, Michel
Related research
Other NIH-funded projects on the same topics.
-
Digital malaria surveillance in Ethiopia to improve outbreak detection
A collaboration to add a malaria-specific digital module to an existing surveillance system in Africa to help detect and respond to outbreaks faster.
-
Cross-sector partnership uses digital malaria surveillance in Ethiopia
A US-based team will adapt and test a digital malaria surveillance module in SORMAS to help detect and respond to malaria outbreaks in Ethiopia.
-
Malaria control project in Western Kenya to reduce illness and deaths
A large, multi-year effort in western Kenya will help track malaria spread and test ways to prevent transmission so fewer people get sick or die.
-
Optimizing tafenoquine dose to prevent relapse of vivax malaria in Asia
A study tests the best tafenoquine dose to prevent P. vivax malaria relapse in people in East Asia and Oceania.
-
Optimizing tafenoquine dose to prevent P. vivax malaria relapses in Asia
A study to find the best single-dose tafenoquine amount to prevent relapse of P. vivax malaria in people in East Asia and Oceania.
-
Severe malaria and brain risk in children
This grant studies how severe malaria in young children can affect brain development and long-term thinking and behavior, with a focus on kids in Uganda.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.